This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Restated FY26 results, Rs 7 dividend, Q1 FY27 results approved
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.7 pts more than Nifty Microcap 250 and 5.6 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved revised FY26 audited results after an ERP configuration error understated raw material costs by Rs 694.63 lakhs. Restated FY26 PAT fell to Rs 582.42 lakhs from Rs 1,103.71 lakhs. Auditor gave unmodified opinion with emphasis of matter. Final dividend of Rs 7 per share stays unchanged. Q1 FY27 PAT dropped sharply to Rs 89.03 lakhs versus Rs 660.89 lakhs a year ago. AGM on September 29, 2026.
FY26 profit restated lower by 47 percent. Q1 FY27 earnings sharply down. Dividend unchanged at Rs 7 per share.
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹96.07 Cr | ₹66.66 Cr | +44.1% |
| Operating profit | ₹6.71 Cr | −₹0.67 Cr | turned positive |
| Profit after tax | ₹6.61 Cr | ₹0.89 Cr | +642.3% |
| EBITDA margin | 12.7% | 7.2% | +5.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.